{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:53:18Z","timestamp":1791395598169,"version":"4.3.3"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["MOBTT39"],"award-info":[{"award-number":["MOBTT39"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004012","name":"Jane ja Aatos Erkon S\u00c3\u00a4\u00c3\u00a4ti\u00c3\u00b6","doi-asserted-by":"publisher","award":["170046"],"award-info":[{"award-number":["170046"]}],"id":[{"id":"10.13039\/501100004012","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.antiviral.2018.04.016","type":"journal-article","created":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T13:36:53Z","timestamp":1524490613000},"page":"174-182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"special_numbering":"C","title":["Novel activities of safe-in-human broad-spectrum antiviral agents"],"prefix":"10.1016","volume":"154","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7780-482X","authenticated-orcid":false,"given":"Aleksandr","family":"Ianevski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Zusinaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suvi","family":"Kuivanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e5rten","family":"Strand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilde","family":"Lysvand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Teppor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Kakkola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Paavilainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Laajala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannimari","family":"Kallio-Kokko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miia","family":"Valkonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anu","family":"Kantele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaidi","family":"Telling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irja","family":"Lutsar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pille","family":"Letjuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalja","family":"Metelitsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentyn","family":"Oksenych","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnar","family":"Bj\u00f8r\u00e5s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svein Arne","family":"Nordb\u00f8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uga","family":"Dumpis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astra","family":"Vitkauskiene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3287-3549","authenticated-orcid":false,"given":"Christina","family":"\u00d6hrmalm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9684-7887","authenticated-orcid":false,"given":"K\u00e5re","family":"Bondeson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Bergqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tero","family":"Aittokallio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca J.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6034-4807","authenticated-orcid":false,"given":"Magnus","family":"Evander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veijo","family":"Hukkanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4592-5926","authenticated-orcid":false,"given":"Varpu","family":"Marjomaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilkka","family":"Julkunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olli","family":"Vapalahti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanel","family":"Tenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Merits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Kainov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2018.04.016_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.293","article-title":"Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases","volume":"5","author":"Al-Bari","year":"2017","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.antiviral.2018.04.016_bib2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.antiviral.2014.10.012","article-title":"Insights into the mechanism of action of cidofovir and other acyclic nucleoside phosphonates against polyoma- and papillomaviruses and non-viral induced neoplasia","volume":"114","author":"Andrei","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.04.016_bib3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.chom.2016.07.004","article-title":"A screen of FDA-approved drugs for inhibitors of Zika virus infection","volume":"20","author":"Barrows","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2018.04.016_bib4","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1099\/vir.0.069864-0","article-title":"Novel inhibitors of human immunodeficiency virus type 2 infectivity","volume":"95","author":"Beach","year":"2014","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2018.04.016_bib5","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1126\/science.aaa3778","article-title":"Infectious disease. Combating emerging viral threats","volume":"348","author":"Bekerman","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2018.04.016_bib6","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1172\/JCI89857","article-title":"Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum antiviral effects","volume":"127","author":"Bekerman","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.antiviral.2018.04.016_bib7","first-page":"59","article-title":"Statins in HIV-infected patients: potential beneficial effects and clinical use","volume":"19","author":"Bernal","year":"2017","journal-title":"AIDS Rev."},{"key":"10.1016\/j.antiviral.2018.04.016_bib8","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.antiviral.2014.03.017","article-title":"Use of FDA approved therapeutics with hNTCP metabolic inhibitory properties to impair the HDV lifecycle","volume":"106","author":"Blanchet","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.04.016_bib9","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nrd.2017.33","article-title":"Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond","volume":"16","author":"Boldescu","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.antiviral.2018.04.016_bib10","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1084\/jem.20170957","article-title":"Inhibition of autophagy limits vertical transmission of Zika virus in pregnant mice","volume":"214","author":"Cao","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2018.04.016_bib11","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1093\/infdis\/jiv392","article-title":"Treatment with lopinavir\/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset","volume":"212","author":"Chan","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.04.016_bib12","unstructured":"Clinical Trial Resources. 2018a. . www.centerwatch.com."},{"key":"10.1016\/j.antiviral.2018.04.016_bib13","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/S0140-6736(17)32130-X","article-title":"Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"390","author":"DALYs","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2018.04.016_bib14","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.2174\/0929867322666150625094705","article-title":"Curious (old and new) antiviral nucleoside analogues with intriguing therapeutic potential","volume":"22","author":"De Clercq","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.antiviral.2018.04.016_bib15","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/CMR.00102-15","article-title":"Approved antiviral drugs over the past 50 years","volume":"29","author":"De Clercq","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.antiviral.2018.04.016_bib16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.virusres.2016.11.011","article-title":"Alisporivir inhibits MERS- and SARS-coronavirus replication in cell culture, but not SARS-coronavirus infection in a mouse model","volume":"228","author":"de Wilde","year":"2017","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2018.04.016_bib17","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/QCO.0000000000000212","article-title":"The future of antivirals: broad-spectrum inhibitors","volume":"28","author":"Debing","year":"2015","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.04.016_bib18","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/jmv.22019","article-title":"Chikungunya disease and chloroquine treatment","volume":"83","author":"Delogu","year":"2011","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2018.04.016_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/v8120322","article-title":"Chloroquine, an endocytosis blocking agent, inhibits Zika virus infection in different cell models","volume":"8","author":"Delvecchio","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2018.04.016_bib20","doi-asserted-by":"crossref","first-page":"35324","DOI":"10.1074\/jbc.M112.392142","article-title":"Obatoclax, saliphenylhalamide, and gemcitabine inhibit influenza a virus infection","volume":"287","author":"Denisova","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2018.04.016_bib21","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"390","author":"Disease","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2018.04.016_bib22","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1056\/NEJMoa1601824","article-title":"Zika virus infection with prolonged maternal viremia and fetal brain abnormalities","volume":"374","author":"Driggers","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2018.04.016_bib23","unstructured":"DrugBank. 2018b. https:\/\/www.drugbank.ca\/."},{"key":"10.1016\/j.antiviral.2018.04.016_bib24","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1126\/science.309.5743.1976a","article-title":"Infectious disease. Old drugs losing effectiveness against flu; could statins fill gap?","volume":"309","author":"Enserink","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2018.04.016_bib25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/lt.20532","article-title":"Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of a sustained virological response after liver transplantation","volume":"12","author":"Firpi","year":"2006","journal-title":"Liver Transpl."},{"key":"10.1016\/j.antiviral.2018.04.016_bib26","doi-asserted-by":"crossref","first-page":"8880","DOI":"10.1128\/JVI.00354-15","article-title":"Biology of Zika virus infection in human skin cells","volume":"89","author":"Hamel","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.04.016_bib27","doi-asserted-by":"crossref","first-page":"9412","DOI":"10.1073\/pnas.1511144112","article-title":"Targeting of mTOR catalytic site inhibits multiple steps of the HIV-1 lifecycle and suppresses HIV-1 viremia in humanized mice","volume":"112","author":"Heredia","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2018.04.016_bib28","doi-asserted-by":"crossref","first-page":"6108","DOI":"10.1073\/pnas.100133697","article-title":"A DNA transfection system for generation of influenza A virus from eight plasmids","volume":"97","author":"Hoffmann","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2018.04.016_bib29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-3-0348-8171-5_2","article-title":"Pleiotropic mechanisms of ribavirin antiviral activities","volume":"59","author":"Hong","year":"2002","journal-title":"Prog. Drug Res."},{"key":"10.1016\/j.antiviral.2018.04.016_bib30","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1038\/emi.2012.47","article-title":"Emerging virus diseases: can we ever expect the unexpected?","volume":"1","author":"Howard","year":"2012","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.antiviral.2018.04.016_bib31","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1038\/s41598-018-20362-9","article-title":"Anti-Rift Valley fever virus activity in vitro, pre-clinical pharmacokinetics and oral bioavailability of benzavir-2, a broad-acting antiviral compound","volume":"8","author":"Islam","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2018.04.016_bib32","unstructured":"JavaScript library D3.js v4. 2018c. http:\/\/d3js.org\/."},{"key":"10.1016\/j.antiviral.2018.04.016_bib33","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.antiviral.2016.11.003","article-title":"Efficacy of the broad-spectrum antiviral compound BCX4430 against Zika virus in cell culture and in a mouse model","volume":"137","author":"Julander","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.04.016_bib34","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.virol.2010.11.012","article-title":"Mutations in nsP1 and PE2 are critical determinants of Ross River virus-induced musculoskeletal inflammatory disease in a mouse model","volume":"410","author":"Jupille","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2018.04.016_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2015.10.011","article-title":"Synergistic antiviral activity of gemcitabine and ribavirin against enteroviruses","volume":"124","author":"Kang","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.04.016_bib36","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.antiviral.2015.05.004","article-title":"Characterizing the effect of bortezomib on Rift valley fever virus multiplication","volume":"120","author":"Keck","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.04.016_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2010.10.009","article-title":"Cellular IMPDH enzyme activity is a potential target for the inhibition of Chikungunya virus replication and virus induced apoptosis in cultured mammalian cells","volume":"89","author":"Khan","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.04.016_bib38","doi-asserted-by":"crossref","first-page":"8884","DOI":"10.1128\/JVI.03415-12","article-title":"Echovirus 1 entry into polarized Caco-2 cells depends on dynamin, cholesterol, and cellular factors associated with macropinocytosis","volume":"87","author":"Krieger","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.04.016_bib39","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.antiviral.2016.12.022","article-title":"Obatoclax, saliphenylhalamide and gemcitabine inhibit Zika virus infection in vitro and differentially affect cellular signaling, transcription and metabolism","volume":"139","author":"Kuivanen","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.04.016_bib40","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s15010-003-3094-5","article-title":"Valaciclovir for chronic hepatitis B virus infection after lung transplantation","volume":"32","author":"Laube","year":"2004","journal-title":"Infection"},{"key":"10.1016\/j.antiviral.2018.04.016_bib41","doi-asserted-by":"crossref","first-page":"115315","DOI":"10.18632\/oncotarget.23258","article-title":"Gemcitabine, a broad-spectrum antiviral drug, suppresses enterovirus infections through innate immunity induced by the inhibition of pyrimidine biosynthesis and nucleotide depletion","volume":"8","author":"Lee","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.antiviral.2018.04.016_bib42","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.bbrc.2016.07.029","article-title":"Drug repurposing of minocycline against dengue virus infection","volume":"478","author":"Leela","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2018.04.016_bib43","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000360948","article-title":"Inhibitors of hepatitis B virus attachment and entry","volume":"57","author":"Lempp","year":"2014","journal-title":"Intervirology"},{"key":"10.1016\/j.antiviral.2018.04.016_bib44","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1128\/JVI.76.4.1856-1865.2002","article-title":"Internalization of echovirus 1 in caveolae","volume":"76","author":"Marjomaki","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.04.016_bib45","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.antiviral.2017.11.013","article-title":"Prevention and treatment of respiratory viral infections: presentations on antivirals, traditional therapies and host-directed interventions at the 5th ISIRV Antiviral Group conference","volume":"149","author":"McKimm-Breschkin","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.04.016_bib46","first-page":"803","article-title":"Effect of ezetimibe in HCV viral load after liver transplantation","volume":"15","author":"Monrroy-Bravo","year":"2016","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.antiviral.2018.04.016_bib47","doi-asserted-by":"crossref","first-page":"6759","DOI":"10.1128\/JVI.00342-16","article-title":"A novel open and infectious form of echovirus 1","volume":"90","author":"Myllynen","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.04.016_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064200","article-title":"A herpes simplex virus-derived replicative vector expressing LIF limits experimental demyelinating disease and modulates autoimmunity","volume":"8","author":"Nygardas","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2018.04.016_bib49","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.antiviral.2017.12.012","article-title":"Deciphering the potential of baicalin as an antiviral agent for Chikungunya virus infection","volume":"150","author":"Oo","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.04.016_bib50","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1002\/jmv.24578","article-title":"Inhibition of clinical pathogenic herpes simplex virus 1 strains with enzymatically created siRNA pools","volume":"88","author":"Paavilainen","year":"2016","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2018.04.016_bib51","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1128\/AAC.00189-09","article-title":"Cyclosporine inhibits flavivirus replication through blocking the interaction between host cyclophilins and viral NS5 protein","volume":"53","author":"Qing","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2018.04.016_bib52","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00569-17","article-title":"Minocycline has anti-inflammatory effects and reduces cytotoxicity in an ex vivo spinal cord slice culture model of west nile virus infection","volume":"91","author":"Quick","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.04.016_bib53","doi-asserted-by":"crossref","first-page":"W495","DOI":"10.1093\/nar\/gkx384","article-title":"C-SPADE: a web-tool for interactive analysis and visualization of drug screening experiments through compound-specific bioactivity dendrograms","volume":"45","author":"Ravikumar","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2018.04.016_bib54","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1016\/j.bmc.2016.03.052","article-title":"Synergistic reduction of HIV-1 infectivity by 5-azacytidine and inhibitors of ribonucleotide reductase","volume":"24","author":"Rawson","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.antiviral.2018.04.016_bib55","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12944-015-0054-x","article-title":"Lipid lowering efficacy and safety of Ezetimibe combined with rosuvastatin compared with titrating rosuvastatin monotherapy in HIV-positive patients","volume":"14","author":"Saeedi","year":"2015","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.antiviral.2018.04.016_bib56","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nm.2581","article-title":"Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor","volume":"18","author":"Sainz","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2018.04.016_bib57","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1089\/dna.2017.4033","article-title":"Repurposing of kinase inhibitors as broad-spectrum antiviral drugs","volume":"37","author":"Schor","year":"2018","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.antiviral.2018.04.016_bib58","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/imm.12246","article-title":"Minocycline attenuates HIV-1 infection and suppresses chronic immune activation in humanized NOD\/LtsZ-scidIL-2Rgamma(null) mice","volume":"142","author":"Singh","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.antiviral.2018.04.016_bib59","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.antiviral.2015.12.011","article-title":"Immuno-modulating properties of saliphenylhalamide, SNS-032, obatoclax, and gemcitabine","volume":"126","author":"Soderholm","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.04.016_bib60","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/jac\/dkr215","article-title":"Directly acting antivirals against hepatitis C virus","volume":"66","author":"Soriano","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2018.04.016_bib61","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1128\/JVI.03192-15","article-title":"Effects of an in-frame deletion of the 6k gene locus from the genome of Ross river virus","volume":"90","author":"Taylor","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.04.016_bib62","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1128\/AAC.02182-15","article-title":"Screening of a library of FDA-approved drugs identifies several enterovirus replication inhibitors that target viral protein 2C","volume":"60","author":"Ulferts","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2018.04.016_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151616","article-title":"Versatile trans-replication systems for chikungunya virus allow functional analysis and tagging of every replicase protein","volume":"11","author":"Utt","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2018.04.016_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-405880-4.00001-9","article-title":"Antiviral agents for herpes simplex virus","volume":"67","author":"Vere Hodge","year":"2013","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.antiviral.2018.04.016_bib65","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/j.bmc.2016.04.018","article-title":"Design, discovery, modelling, synthesis, and biological evaluation of novel and small, low toxicity s-triazine derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitors","volume":"24","author":"Viira","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.antiviral.2018.04.016_bib66","series-title":"WHO Publishes List of Top Emerging Diseases Likely to Cause Major Epidemics","author":"WHO","year":"2015"},{"key":"10.1016\/j.antiviral.2018.04.016_bib67","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006866","article-title":"HIV: cell binding and entry","volume":"2","author":"Wilen","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.antiviral.2018.04.016_bib68","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1086\/592116","article-title":"Ezetimibe alone reduces low-density lipoprotein cholesterol in HIV-infected patients receiving combination antiretroviral therapy","volume":"47","author":"Wohl","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.04.016_bib69","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.antiviral.2017.07.007","article-title":"Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo","volume":"145","author":"Yuan","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.04.016_bib70","doi-asserted-by":"crossref","first-page":"9218","DOI":"10.1074\/jbc.M116.716100","article-title":"Glycopeptide antibiotics potently inhibit cathepsin L in the late endosome\/lysosome and block the entry of ebola virus, Middle East respiratory syndrome coronavirus (MERS-CoV), and severe acute respiratory syndrome coronavirus (SARS-CoV)","volume":"291","author":"Zhou","year":"2016","journal-title":"J. Biol. Chem."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218300986?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218300986?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:29:39Z","timestamp":1759062579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354218300986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":70,"alternative-id":["S0166354218300986"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.04.016","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel activities of safe-in-human broad-spectrum antiviral agents","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}